¿Qué sabemos realmente sobre la eficacia de las vacunas contra covid?
¿Lo esencial? Vacunarse con cualquiera de las tres vacunas disponibles en los Estados Unidos disminuye la posibilidad de infectarse en primer lugar y reduce de manera significativa el riesgo de hospitalización o muerte si se contrae el coronavirus y se desarrolla covid-19.
Insurance Focused on Virtual Visits? The Pros and Cons of a New Twist in Health Plans
New, often lower-cost plans capitalize on the convenience of telemedicine — and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.
Surprise-Billing Rule ‘Puts a Thumb on the Scale’ to Keep Arbitrated Costs in Check
Patients soon will not have to worry about the prospect of these often-costly unexpected bills, a federal law promises. Some experts say the new policy could also slow the growth of health insurance premiums.
Biden Releases a New Plan to Combat Covid, but Experts Say There’s Still a Ways to Go
There’s agreement that the plan includes important action items but also elements that will trigger political opposition.
Census: Insured Population Holds Steady, With a Slight Shift From Private to Public Coverage
The Census Bureau on Tuesday released its 2020 findings regarding Americans’ income, poverty and health insurance coverage.
Telehealth’s Limits: Battle Over State Lines and Licensing Threatens Patients’ Options
Televisits took off during the worst days of the pandemic, but states are now rolling back the temporary rules that facilitated them. That’s adding fuel to debates about states’ authority over medical licensing.
If the Unvaccinated Want to Work, They Face a Series of Hurdles
As employers create safety protocols for workers who refuse vaccination, we ask experts if they really work. Or is the point to pressure employees into getting a shot?
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Health plans’ coverage of the medication, branded as Wegovy — which has a $1,300-a-month price tag — is not a sure thing.
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.
Hospital Prices Must Now Be Transparent. For Many Consumers, They’re Still Anyone’s Guess.
A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.